Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy Participants
Clinical trial NCT02982707 · COMPLETED
Trial details
- NCT number
- NCT02982707
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2018-09-28
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.